ArticleNature reviews. Rheumatology2010

Therapy: Rituximab has similar short-term safety and efficacy to cyclophosphamide in ANCA-associated vasculitis.

Shreeya NandaPubMed ↗Publisher ↗

No numbers read from the abstract.